Abstract. Octyl gallate inhibited the multiplication of several RNA viruses with widely different structure and replication strategies; i.e. vesicular stomatitis virus (VSV), influenza virus and poliovirus. In addition, octyl gallate showed virucidal activity against enveloped viruses at high concentrations. Characterization of the mode of action of octyl gallate against influenza virus infection revealed that the reagent delayed the onset of progeny virus formation. It did not, however, affect the rate of the formation, and the addition of the reagent at 2 h postinfection (p.i.), but not at 4 h p.i., almost completely abolished the formation of the progeny viruses, suggesting that the antiviral action of octyl gallate was not the result of a non-specific degeneration of the infected cells, but possibly the result of the inhibition at specific steps in the middle stage of the multiplication of influenza virus.
Introduction
Gallic acid (3,4,5-trihydroxybenzoic acid) is obtained by alkaline or acid hydrolysis of the tannins from nutgalls. It is one of the popular natural products of a variety of plants. Gallic acid and the alkyl derivatives are attracting attention due to their various pharmacological activities (1, 2) . Some gallate derivatives have been well characterized and, because of their limited cytotoxity, are currently used as antioxidant food additives or as quasi drugs in Europe and Japan.
Previously, we systematically characterized the antiviral activity of n-alkyl esters of gallic acid and found a relationship between the number of carbon atoms in the alkyl moiety of the molecules and their antiviral activity against herpes simplex virus type 1 (HSV-1) (3). However, regarding its activity against RNA viruses, we observed that octyl gallate, one of the alkyl gallates, affected the multiplication of the RNA virus, vesicular stomatitis virus (VSV), while others reported that methyl gallate was ineffective against RNA viruses, such as VSV and influenza virus (4), but was effective against HSV-1, consistent with our observation of octyl gallate. To solve this discrepancy concerning the antiviral activity of alkyl gallates against RNA viruses and to further explore the potential usefulness of octyl gallate as an antiviral drug against a wide range of viruses, we examined the effect of octyl gallate on the multiplication of a variety of RNA viruses with widely different structure and replication strategies.
Materials and methods
Cells and viruses. MDCK, HEp-2 and Vero cells were grown in Eagle's minimum essential medium (MEM) containing 10% newborn calf serum. Influenza virus A/Aichi (H 3 N 2 ), poliovirus type 1 (Sabin strain), and VSV (New Jersey strain) were used throughout the experiments. The viruses were propagated in MDCK cells (for influenza virus) in MEM supplemented with 0.1% bovine serum albumin (BSA) and acetylated trypsin (4 μg/ml); or in Vero cells (for poliovirus and VSV) in MEM supplemented with 0.5% fetal bovine serum. These viruses were stored at -80˚C until use. The amount of each virus was measured by a plaque assay as described previously (5-7).
Virus yields in the presence of octyl gallate. The structure of octyl gallate is shown in Fig. 1 . Octyl gallate was obtained from Tokyo Kasei. A stock solution (2.0 or 10.0 mg/ml) was prepared by dissolving the reagent in dimethylsulfoxide, followed by filtration through a Millipore DIMEX membrane (pore size 0.22 μm) and was then stored in the dark at room temperature until use.
Monolayered cells in 35-mm dishes were infected with the virus at an indicated multiplicity of infection (MOI). The infected cells were further incubated at 37˚C (for VSV and influenza virus) or 35.5˚C (for poliovirus) for the indicated periods in serum-free MEM containing 0.1% BSA and the indicated concentrations of octyl gallate. For the experiments with influenza virus, acetylated trypsin (4 μg/ml) was also added to the medium for the activation of virus infectivity. At the end of infection, the culture medium was harvested and the amounts of total progeny virus in the medium were determined. For poliovirus, the progeny virus was harvested from both the culture media and the infected cells, which were lysed by two cycles of freezing and thawing. 
Determination of cytopathic effects and cell death by infection with influenza virus.
Monolayers of MDCK cells were mock-infected or infected with influenza virus at the indicated MOI. The infected cells were incubated in the serum-free MEM containing 0.1% BSA, acetylated trypsin (4 μg/ml) and the indicated concentrations of octyl gallate. The cytopathic effects (CPE) were determined by a microscopic observation of the cells; approximate amounts of rounded cells on monolayers were estimated under a phasecontrast microscope.
To determine the extent of cell death in the cultures, monolayered cells were trypsinized to obtain a single-cell suspension. After the addition of MEM containing 10% calf serum to the suspension to neutralize the trypsin and to stabilize the cells, the number of living and dead cells was determined by a dye-exclusion method with trypan blue.
Results and discussion

Effect of octyl gallate on the multiplication of RNA viruses.
To examine the effects of octyl gallate on RNA viruses in general, we tested three different types of viruses; VSV (Rhabdoviridae family), influenza virus (Orthomyxoviridae family) and poliovirus (Picornaviridae family). Both VSV and influenza virus are enveloped viruses carrying a negativestranded RNA as a genome, but the former can replicate sufficiently in the cell cytoplasm, while the latter absolutely requires the cell nucleus for virus multiplication (8) . In contrast, poliovirus is a non-enveloped virus carrying a positive-stranded RNA as a genome which replicates in the cytoplasm of the infected cells (9) . Fig. 2 shows the effects of octyl gallate on the relative virus yields of these three viruses, when the infected cells were incubated in medium containing various concentrations of the reagent. The multiplication of VSV was highly sensitive to octyl gallate; the virus yield sharply decreased as the reagent concentration was increased to 8 μg/ml. In the presence of 4 μg/ml of the reagent, the yield reached less than one hundredth of that in the absence of the reagent. This sensitivity of VSV was comparable to the reagent sensitivity of HSV-1, an enveloped double-stranded DNA virus (3). Although both influenza virus and poliovirus were less sensitive to the reagent than VSV, the multiplication of these two viruses was also affected by octyl gallate; the progeny virus yields of these two viruses showed a similar dosedependent decrease. A five-fold higher concentration (20 μg/ ml) was required for influenza virus and poliovirus than the concentration for VSV to achieve a 100-fold decrease in the yield (Fig. 2) . These results clearly show that octyl gallate inhibits the multiplication of these RNA viruses which are widely different both in structure (i.e. enveloped or nonenveloped; positive-or negative-stranded genome RNA) and in their method of genome replication and transcription (i.e. in the nucleus or in the cytoplasm of the infected cells). These results are inconsistent with those of Kane et al (4) who previously reported that methyl ester of gallic acid effectively inhibits the multiplication of HSV-1, but not RNA viruses, such as VSV and influenza virus. We are uncertain whether this discrepancy concerning the antiviral effects of alkyl gallate on RNA viruses was due to the difference in chemical structure (octyl vs methyl) or in the assay conditions. In addition, it is worth noting that the antiviral activity of the reagent was apparently independent of the type of cells used; i.e. the multiplication of influenza virus was examined on MDCK cells (derived from canine kidney cells) while that of VSV or poliovirus was examined on HEp-2 cells (derived from human cervical carcinoma).
Virucidal effect of octyl gallate. Previously we found that octyl gallate directly inactivated HSV-1 at relatively high reagent concentrations. As shown in Fig. 3 , the reagent was also able to inactivate VSV and influenza virus in a concentration-dependent manner, but not poliovirus at the tested range of concentrations. While both influenza virus and VSV are enveloped viruses, the observed virucidal effect of octyl gallate was clearly stronger on VSV than on influenza virus. HSV-1 was similar to VSV in its sensitivity to the reagent (3). Direct virucidal activity was also reported for other gallate derivatives, epigallocatechin-3-gallate and prodelphinidin B-2 3'-O-gallate (10-12), but the basis for the virucidal activity of the reagent remains unclear.
A time course study showed that the inactivation of the viruses by octyl gallate was rapid, occurring immediately after mixing the virus preparation with the reagent (data not shown). Previously we proposed a possible participation of antioxidant action of gallic moiety of the reagent in this direct inactivation of the viruses (3). However, when influenza virus was incubated systematically with a series of alkyl esters of gallic acids to a concentration of 120 μg/ml, we found that, while ethyl, butyl and hexyl esters of gallic acid showed very weak virucidal activity, both decyl and lauryl esters showed much stronger activity than did octyl gallate. These results indicate that the gallic moiety alone is insufficient for the observed virucidal activity of these esters, and the alkyl group of the molecules plays an important role in this activity. Our previous proposal that the virucidal activity was caused by the antioxidant action of the reagent seems less likely. The alternative explanation is that the observed virucidal activity of the gallate esters with longer alkyl chains is due to the hydrophobic interaction between the alkyl chains and virion components, as is evident from the chemical structure (Fig. 1 ). This explanation is also supported by the observation that octyl gallate was less effective when higher concentrations of BSA were present in the medium (data not shown). This was probably due to the effect of decreased free octyl gallate concentrations on the binding of the reagent to BSA by hydrophobic interaction between these two molecules.
Considering the potential applications of octyl gallate as an antiviral drug against influenza virus, we further characterized the mode of action of this reagent on the multiplication of influenza virus.
Multiplication of influenza virus in the presence of octyl gallate.
Multiplication of influenza virus in the virus-infected cells proceeds as described below (8) . Following the binding to the cell surface receptor, the virus particle is endocytosed, and viral nucleocapsids are released from the particle into the A group of confluent monolayers of MDCK cells were infected with influenza virus at an MOI of 14 and were incubated in MEM containing 0.1% BSA and acetylated trypsin (4 μg/ml). At various times after the infection, octyl gallate was added to the culture medium at a final concentration of 16 μg/ml and then the infected cells were further incubated in the presence of the reagent. The amount of progeny virus in each culture was determined at 14 h p.i.
cytoplasm. Subsequently the expression of viral genes begins and the replication of the genome RNA and the formation of nucleocapsids take place in the infected cells. The assembly of nucleocapsids occurs beneath the plasma membrane, followed by the envelopment of nucleocapsids concomitantly with the budding at the plasma membrane and the formation of progeny virus. Fig. 4A and B show one-step growth curves of influenza virus in the presence or absence of octyl gallate. In the absence of the reagent, the progeny infectious virus appeared after 4 h postinfection (p.i.), increased rapidly for the following 4 h and reached a plateau at ~10 h p.i. However, in the presence of the reagent at 12 μg/ml (Fig. 4A) , the onset of infectious progeny virus production was delayed for ~1 h, and the final virus yield was significantly less than the yield observed in the absence of the reagent, although the rate of the increase in the amount of progeny virus was not significantly affected by the reagent. At a higher reagent concentration (16 μg/ml), the onset of progeny virus production was further delayed for 4 h and the final yield under these conditions was highly suppressed (Fig. 4B ). These one-step growth curves suggest that the reagent effectively slows down the progress of some steps in the early stage (i.e. before the envelopment of nucleocapsids at the plasma membrane) in the multiplication of influenza virus.
Previously we observed that the acceleration of cell death in the virus-infected cells was usually accompanied by a significant decrease in the progeny virus production (13, 14) . In addition, the previous characterization of the antiherpetic action of octyl gallate (3) revealed that the reagent selectively accelerated both CPE and cell death in the virus-infected cells relative to those in the uninfected cells. Based on these observations we proposed that octyl gallate inhibits the virus multiplication as a result of acceleration of selective CPE and cell death in the virus-infected cells by the reagent (3). However, in contrast to HSV-1, influenza virus induced CPE in the infected MDCK cells so rapidly after infection that the acceleration of CPE by octyl gallate could not be detected in the influenza virus-infected cells. Consistent with these observations on CPE, the induction of infected cell death was only slightly accelerated, if any, in the presence of the reagent at 12 or 16 μg/ml (data not shown).
Reagent-sensitive step in the virus multiplication. It has been reported by studies on the antiviral action of epigallocatechin-3-gallate and other polyphenolic compound catechins that the inhibition of influenza virus multiplication can occur at multiple stages in the virus replication cycle, such as during receptor binding, viral RNA synthesis and neuraminidase activity (12) . To investigate the octyl gallate-sensitive step(s) in the multiplication of influenza virus, we added the reagent to the culture medium of the influenza virus-infected cells at various time post infection and harvested the progeny virus at the end of virus multiplication (14 h p.i.). As shown in Fig. 5 , the reagent efficiently inhibited the formation of the progeny virus when added within a time period of 2 h p.i., but was much less effective at 4 h p.i.; there was essentially no effect by the addition of the reagent after 6 h p.i. These results indicate that initially, there is a critical reagent-sensitive step after the binding and entry step, since the addition of the reagent at 2 h p.i. effectively inhibited the virus multiplication, and second, there is no critical reagent-sensitive step in the late stage (6 h p.i. or later) of the virus multiplication, as addition of the reagent at this stage was ineffective. Judging from this critical period sensitive to octyl gallate, the reagent-sensitive steps in the virus multiplication are likely at transcription and/or at replication of the viral genome in the influenza virus-infected cells. If the observed in vitro virucidal effect of octyl gallate translates to an in vivo effect, then the binding of the reagent to certain cellular components or structures at this stage may be responsible for the inhibition of virus multiplication. We are now investigating the target of this possible binding in the infected cells.
